Pirivigen 10% intravenous injection 5g/50mL (YJ code: 6343427A7038, standard: 5g x 50mL x 1 bottle) from CSL Behring is a pH4-treated acidic human immunoglobulin. It is used for replacement therapy in primary immunodeficiency diseases and as immunomodulatory therapy for conditions like chronic immune thrombocytopenic purpura (ITP) and chronic inflammatory demyelinating polyneuropathy (CIDP).
Pirivigen 10% intravenous injection 5g/50mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →